Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Outsourcing Perspectives from Ron Connolly of Frontage Labs

September 3, 2014

Ron Connolly, vice president of commercial operations at Frontage Labs, provided commentary on the role of contract services in analytical services.

Targeting Different Off-Shore Destinations

September 2, 2014

Pharmaceutical Technology

Annual study shows geographic proximity not a factor in CMO selection.

Outsourcing Perspectives from Xcelience

September 2, 2014

Experts at Xcelience provided commentary on the evolving role of contract services in analytical services and solid/semi-solid development manufacturing.

Outsourcing Perspectives from Baxter BioPharma Solutions

September 2, 2014

Experts from Baxter BioPharma Solutions provided the following commentary on trends in bio/pharmaceutical development outsourcing.

Outsourcing Perspectives from John Sandles of Fujifilm Diosynth Biotechnologies

September 2, 2014

John Sandles, Business Analyst for Fujifilm Diosynth Biotechnologies, provided commentary on the evolving role of contract services in biologics drug development and manufacturing.

Contract Packagers Expand to Meet Demand

August 20, 2014

Equipment and Processing Report

Recent packaging expansions include both acquisitions and new equipment and services.

Fast Locator 2014-2015 Index

August 18, 2014

View companies' outsourcing profiles from PharmTech's 2014 Outsourcing Resources Fast Locator Index in the following categories.

Acute Need for Supply Chain Transparency

August 4, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

Biopharma manufacturers must reduce the risk in their complex supply chains

Relationship-building at Top of Mind for Clients

August 2, 2014

Pharmaceutical Technology

Annual study shows CMO technical expertise is not enough.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here